ASR vs GEV

ASR exhibits strong financial health with a Piotroski F-Score of 7/9, indicating solid operational and balance sheet strength. Profitability metrics are robust, with high margins and ROE above sector average, while leverage remains low. However, recent earnings declines and poor earnings surprise trends—four consecutive misses with double-digit negative surprises—raise concerns about near-term execution. The stock trades significantly above the Graham Number of $64.05, reflecting premium valuation despite weak earnings growth, though it aligns more closely with the growth-based intrinsic value of $181.09.

GE Vernova Inc. (GEV) trades at a significant premium to both the industrials sector and its closest peers, with a P/E of 94.34 versus a sector average of 27.54, raising valuation concerns despite strong 5-year price appreciation of +341.7%. The company exhibits solid revenue growth at 11.8% YoY and improving profitability trends, including a ROE of 16.72% and low leverage (Debt/Equity: 0.11), but erratic earnings performance and negative Q/Q EPS growth (-23.7%) undermine confidence in sustained momentum. Analysts are bullish with a $679.30 target price implying ~17% upside, yet insider selling—particularly a $2.05M CFO sale—contradicts this optimism. While financial health is stable and growth fundamentals show promise, stretched valuations and inconsistent earnings delivery create a conflicted outlook, warranting caution despite favorable sector positioning.